brca & parp inhibitors: targeted chemotherapy | #markscholzmd #alexscholz @pcri
Published 1 year ago • 4.3K plays • Length 11:49Download video MP4
Download video MP3
Similar videos
-
17:40
genetic testing for prostate cancer | brca | #markscholzmd #alexscholz #pcri
-
14:39
new fda approved parp inhibitor: talzenna (talazoparib) & xtandi | #markscholzmd #alexscholz #pcri
-
16:39
managing terminal prostate cancer | #markscholzmd #alexscholz #pcri
-
0:57
learn about parp inhibitors for #prostatecancer #talzenna #akeega
-
5:15
rucaparib and olaparib: two new treatments approved for advanced prostate cancer | pcri
-
3:30
2020 in review: olaparib & rucaparib, fda approval | ask a prostate expert, mark scholz, md
-
1:15:48
advanced #prostatecancer treatments extended q a | #markscholzmd & #markmoyadmd #pcri
-
18:58
testosterone replacement in #prostatecancer remission | #markscholzmd #alexscholz #pcri
-
13:37
psa after #prostatecancer surgery | #markscholzmd #alexscholz | pcri
-
4:11
brca, msi, and useful genetic tests in prostate cancer | answering youtube comments #45 | pcri
-
16:22
role of parp inhibitors in prostate cancer
-
13:40
2022 recap: new treatments and approaches in #prostatecancer | #markscholzmd | pcri
-
1:01
choosing the correct parp inhibitor for prostate cancer
-
1:12:13
advanced #prostatecancer treatments | eugene kwon, md | diy combat manual | part 5 #pcri
-
2:38
seminar clips: parp inhibitors and brrca1/2 cancers- susan domchek, md | stanford cancer institute
-
1:43
parp inhibitors for prostate cancer
-
8:50
case 4: chemotherapy or parp inhibitors for brca tnbc
-
2:47
what is a parp inhibitor? | dana-farber cancer institute | science illustrated
-
58:03
palb2 management updates and prostate cancer risk & survival